Suggest Dosage For Temozolomide For A Patient With Brain Cancer
What is the customary lead time needed by your medical professionals to provide a comprehensive answer regarding a specialty question?
Please just kindly advise, when I should begin watching my email, to look for a reply. Thank you.
Dosage guidelines mentioned
Detailed Answer:
Thanks for asking on HealthcareMagic.
I have gone carefully through your query. The following information should be useful for you:
* Adjuvant therapy for Grade II (low-grade infiltrative astrocytomas, oligodendroglioma, mixed gliomas) brain cancer includes temozolomide 150-200 mg/sq.m/day orally on days 1-5 of a 28-day cycle for six to eight cycles.
* Recurrences or progressive, low-grade disease (previously untreated): Temozolomide 75 mg/m 2 orally daily on days 1-21 or 150-200 mg/sq.m orally on days 1-5 of a 28-d cycle until disease progression or for a maximum of 24 cycles.
* For Grade III (anaplastic astrocytoma or oligoastrocytoma): The standard of care is surgical resection followed by External Beam Radiation Therapy (EBRT) (60 Gy in 30-35 fractions) and adjuvant temozolomide, 75 mg/sq.m/day orally on days 1-42, usually 1-1.5 hours before radiation.
* For Post–radiation therapy: Temozolomide needs to be continued at higher doses of 150-200 mg/sq.m/day orally on days 1-5 every 28 day.
* For Grade IV (glioblastoma): The standard of care is surgical resection followed by EBRT (60 Gy in 30-35 fractions) and adjuvant temozolomide 75 mg/sq.m/day orally on days 1-42, usually 1-1.5h before radiation.
* Postradiation therapy: Temozolomide needs to be continued at higher doses of 150-200 mg/sq.m/day orally on days 1-5 every 28 days.
I hope that would help.
Typically the response time is an hour or two although occasionally it may take longer.
Feel free to write back.
Regards